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INTRODUCTION
The ubiquitin-proteasome system is present in all living organisms.
It catalyzes the degradation of intracellular proteins and is involved
in the control of a variety of important cellular processes such as
cell division, cell differentiation and apoptosis. More specifically,
the proteasome exhibits multiple peptidase activity referred to as
trypsin-like, chymotrypsin-like and caspase-like activity. It targets
damaged or non-functional proteins that have been tagged for
degradation via ubiquitination (reviewed by Baumeister et al.,
1998; Ciechanover, 2005). Various approaches have been
established for measuring proteasomal activities. Purification
procedures are often chosen to characterize chemical or physical
properties of the proteasome (Dahlmann et al., 2000) whereas
activity measurements in crude or partially purified samples may
indicate its state and the overall activity (Kisselev and Goldberg,
2005). Assays using crude extracts, which contain other
intracellular proteases in addition to the proteasome, run the risk
of cross-reaction with those proteases (Rodgers and Dean, 2003).
Consequently, it is necessary to distinguish proteasomal activity
from that of other proteases.
In recent years, the proteasomes of marine invertebrates have
gained greater research attention, reflecting increasing recognition
of their importance for protein turnover and degradation in the
physiology of these organisms (Mykles, 1998). For example, the
proteasome is thought to play an important role in claw muscle
degradation during the molting process of adult and larval lobsters
(Mykles, 1999b; Götze and Saborowski, 2011a). Bivalves were
established as new model organisms to investigate physiological
processes such as stress tolerance and ageing (Cherkasov et al., 2006;
Ivanina et al., 2008; Philipp and Abele, 2010). The contribution of
the proteasome to these processes is an emerging field of research
(Ungvari et al., 2011).
Besides the comprehensive work on the structure and function
of arthropod proteasomes (Haire et al., 1995; Mykles, 1999a), limited
information exists on the basic characteristics and properties of
proteasome systems of most marine invertebrate taxa. Knowledge
is particularly scarce with respect to the cross-reactivity of non-
proteasomal proteases with the substrates used for proteasome
activity determination in these animals. This knowledge, however,
is crucial for choosing appropriate analytical methods and for the
interpretation of the resulting data. Therefore, the aim of the present
study was to investigate the chymotrypsin-like proteasomal activities
in crude tissue extracts of different crustacean and bivalve species
and to distinguish between proteasomal and non-proteasomal
activities using epoxomicin, a proteasome-specific inhibitor (Meng
et al. 1999; Kisselev and Goldberg, 2001). We focused our study
on the chymotrypsin-like activity, which may serve as an indicator
for the overall proteasomal capacity and which reacts among the
three activity sites most sensitive towards the inhibitor epoxomicin.
This study shows a considerable diversity in the relative shares of
proteasomal and non-proteasomal activities between taxa, which has
to be considered in future proteasome studies in marine invertebrates.
MATERIALS AND METHODS
Total chymotrypsin-like proteolytic activity was measured in the
bivalves Arctica islandica (foot), Mytilus edulis (foot, gill),
Mercenaria mercenaria (gill) and Crassostrea virginica (gill), and
the crustaceans Homarus gammarus (claw muscle), Cancer pagurus
(claw muscle) and Crangon crangon (hemocytes). Cell extracts of
yeast, Saccharomyces cerevisiae, were used as a reference. The
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mussels were placed on ice for 15min and then opened by incisions
through the adductor muscles. The foot and the gills were dissected
and immediately flash-frozen in liquid nitrogen. The remains of the
mussel were immediately shock-frozen as well. The crustaceans
were not killed but were induced to autotomize one claw by carefully
bending the claw away from the body and breaking it at the basi-
ichium joint. The shell of the autotomized claws was crushed and
the muscle tissue was dissected and frozen in liquid nitrogen.
Hemocytes were isolated from the hemolymph as described
previously (Götze and Saborowski, 2011b). The tissues were
homogenized by mortar and pestle in liquid nitrogen and re-
suspended in fourfold volume (v/w) of assay buffer [0.05moll–1
Tris(hydroxymethyl) aminomethane, 0.025moll–1 KCl, 0.01moll–1
NaCl, 0.001moll–1 MgCl2, pH8.0]. The homogenates were
centrifuged for 35min at 4°C and 13,000g. The supernatant was
collected and stored at –80°C until further analysis.
Concentration-dependent response to a specific proteasome
inhibitor, epoxomicin, was determined for each species in 96-well
plates with a total volume of 50μl per assay. The assay contained
40μl assay buffer [0.05moll–1 Tris(hydroxymethyl) aminomethane,
0.025moll–1 KCl, 0.01moll–1 NaCl, 0.001moll–1 MgCl2, and
0.002moll–1 adenosine triphosphate, pH8.0 at 30°C], 5μl of sample
extract and 2.5μl of dimethylsulfoxide (DMSO, as vehicle control)
with epoxomicin at concentrations between 0 and 100mmoll–1. The
reactions were started by addition of 2.5μl of Suc-Leu-Leu-Val-
Tyr-AMC (I-1395, Bachem, Bubendorf, Switzerland; 10mmoll–1
dissolved in DMSO, final concentration in assay 0.5mmoll–1) and
incubated for 1h at 30°C in the dark. Fluorescence was measured
in a Fluoroscan Ascent Microplate Fluorometer (Thermo Scientific,
Dreieich, Germany) at 355nm excitation and 460nm emission
wavelengths.
In a separate set of experiments, the total chymotrypsin-like
proteolytic activities of tissue homogenates were measured in the
absence and presence of 50mmoll–1 of epoxomicin. The share of
activity inhibited by epoxomicin represents the proteasomal activity
while the difference between the total activity and the inhibited share
describes the non-proteasomal activity. The results were calculated
and presented as relative amounts (%) of the total proteolytic activity.
The percent data were arcsin square-root transformed and then
analyzed with a one-way ANOVA and Tukey’s honestly significant
different post hoc test (SPSS ver. 15.0, IBM, Armonk, NY, USA).
RESULTS
The chymotrypsin-like proteasome activities of the crustacean and
bivalve tissues were notably inhibited in the presence of 5mmoll–1
of epoxomicin (Fig.1). The concentration-dependent curve for
epoxomicin inhibition was similar in shape across all taxa, although
it differed in the degree of inhibition, indicative of species-specific
proteasomal contributions to total proteolytic activity (Fig.1). At
10mmoll–1 epoxomicin, most proteasome-like activity was inhibited
with no further change at higher inhibitor concentrations up to
100mmoll–1. The total proteolytic activity in the crustacean and the
yeast samples could be almost exclusively attributed to proteasome-
like activity (Fig.2). In the hemocytes of C. crangon, activity was
completely inhibited by epoxomicin and thus was exclusively of
proteasomal origin (100±0%). In the muscle tissues of H. gammarus
and C. pagurus, proteasomal activity accounted for 96.6±3.6% and
96.6±3.4% of the total proteolytic activity, respectively. The fraction
of total proteolytic activity that could be explained by proteasomal
catalysis was not significantly different among the three studied
crustacean species (P=0.4). The share of proteasome activity was
slightly lower in the whole-cell lysates of S. cerevisiae (90.3±7.8%),
but not significantly different from the muscle extracts of H.
gammarus and C. pagurus (P=0.8). All bivalve samples had a
significantly lower content of proteasomal activity than the
crustacean and the yeast samples. The gill tissue of C. virginica
(64.2±5.5%) and the foot tissue of A. islandica (62.8±11.4%) showed
the highest proteasomal contribution to the total proteolytic activity
among the studied bivalves. Slightly, but not significantly, lower
shares were detected in the gill tissue of M. edulis (44.2±10.2%).
The lowest proteasome-based activity fractions were observed in
the foot tissue of M. edulis (32.7±10.1%) and the gill tissue of M.
mercenaria (23.2±16.1%). In these last two species, the proteasomal
contribution to total proteolytic activity was significantly lower than
in C. virginica and A. islandica.
DISCUSSION
This is the first study to report that cross-reactions, caused by non-
proteasomal proteases, in crude extract assays differ significantly
between marine invertebrate taxa. These findings are highly relevant
for future studies on the proteasome in these organisms.
Our results reveal that when using a common substrate for testing
proteasomal activities with muscle and hemocyte samples of
crustaceans, the risk of obtaining erroneous results is actually quite
low. More than 95% of the total chymotrypsin-like activity was
inhibited by epoxomicin at concentrations as low as 5mmoll–1,
indicating that proteasome-like activity is a near-total contributor to
the chymotrypsin-like activity of these crude crustacean tissue
extracts. In contrast, measure of chymotrypsin-like activities in crude
tissue extracts of marine bivalves cannot provide a reliable estimate
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Fig.1. Example of individual concentration–response curves
for chymotrypsin-like proteolytic activity (%) in response to
different concentrations of the proteasome inhibitor
epoxomicin in crustacean, yeast and bivalve tissues. The
concentrations of epoxomicin in the assay were 5, 12.5, 25,
50 and 100mmoll–1. The tested tissues (from top to bottom)
are: claw muscle of Homarus gammarus and Cancer
pagurus, hemocytes of Crangon crangon, whole-cell lysate
of Saccharomyces cerevisiae, gill tissues of Mytilus edulis,
Crassostrea virginica and Mercenaria mercenaria, foot tissue
of Arctica islandica and mantle tissue of M. edulis.
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of proteasomal activity unless the relative contributions of proteasomal
and non-proteasomal pathways are determined. Therefore, verification
of the cross-reactivity via inhibition with epoxomicin or other highly
proteasome-specific inhibitors (Dick et al., 1996; Kisselev and
Goldberg, 2001; Mykles, 2001) is an essential analytical step when
working with bivalve samples. The inhibitor enables distinction
between proteasomal and non-proteasomal activities and is particularly
important when new species or tissue types are under investigation.
Epoxomicin has been shown to inhibit protease-related proteolytic
activities in mammalian tissues, leaving calcium-dependent or
lysosomal proteases unaffected. It is a natural epoxyketone with a
unique mechanism to inhibit the proteasome but not serine or
cysteine proteases. Therefore, it is the most selective inhibitor of
proteasome known (Kisselev and Goldberg, 2001). The specific
inhibition has been demonstrated in the proteasome of various tissues
and cells, including yeast. Because the proteasome has a very
conservative structure, we assume that epoxomicin acts in
invertebrate proteasomes in the same way as in vertebrate
proteasomes, and therefore is the most suitable inhibitor for studies
on marine invertebrate proteasomes.
The main reason why proteasome assays can be susceptible to
other proteinases is the lack of commercially available proteasome-
specific substrates, such as labeled ubiquitinated proteins, which
are exclusively degraded by the proteasome. Instead, short
fluorophore-labeled peptides are commonly used, which are less
specific and can therefore also be targeted by other proteolytic
enzymes (Rosser et al., 1993; Garcia et al., 1998; Michael et al.,
2005). Of particular importance when preparing crude tissue extracts
is avoiding contamination with digestive enzymes from the gut or
digestive glands of the animals, which may entirely mask the innate
proteasomal activity of the sample (Götze and Saborowski, 2011a;
A.B., personal observation). So, when starting work with new
species the degree of cross-reactivity needs to be determined in crude
extracts of uncontaminated samples.
Commercial proteasome assay kits provide a fast and easy way
of screening proteasome activities. However, because these kits were
designed for use with purified proteasome samples they do not
include proteasome inhibitors. They are therefore not suitable for
distinguishing between proteasomal and non-proteasomal activities
without modifications to the assay protocol. For example, in a study
by Ungvari et al. (Ungvari et al., 2011), proteasomal activities were
determined in crude extracts of gill tissues from the bivalves A.
islandica and M. mercenaria according to the manufacturer’s
instructions with a Proteasome-Glo assay kit (Promega, Mannheim,
Germany). The authors reported similar levels of chymotrypsin-like
activities in both species. Our results, however, reveal that the
northern quahog, M. mercenaria, possesses the lowest share of
chymotrypsin-like proteasomal activity, accounting for
approximately 23% of total activity, whereas the chymotrypsin-like
proteasomal activity in the ocean quahog, A. islandica, contributes
to roughly 60% to the total proteolytic activity. Thus, gill tissues
of A. islandica actually have higher chymotrypsin-like proteasomal
activities than M. mercenaria; however, this cannot be correctly
assayed with common commercial test kits. This led the authors to
the wrong conclusion, namely that chymotrypsin-like activity is
lower in the long-lived A. islandica compared with the relatively
shorter-lived M. mercenaria and, consequently, that there is no
relationship between proteasomal activity and longevity.
In conclusion, verification of the cross-reactivity via inhibition
with epoxomicin or other highly specific proteasome inhibitors (Dick
et al., 1996; Kisselev and Goldberg, 2001) is an essential analytical
step that enables the distinction between proteasomal and non-
proteasomal activities as described here with the example of the
chymotrypsin-like activity. This procedure is particularly important
when new species or tissues are under investigation.
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